Upregulation of MUC4 in cervical squamous cell carcinoma: Pathologic significance

Elizabeth G. Munro, Maneesh Jain, Esther Oliva, Neel Kamal, Subodh M. Lele, Maureen P. Lynch, Lankai Guo, Kai Fu, Poonam K Sharma, Steve Remmenga, Whitfield B. Growdon, John S. Davis, Bo R. Rueda, Surinder K. Batra

Research output: Contribution to journalArticle

15 Scopus citations


MUC4 is a transmembrane glycoprotein more highly expressed in cervical dysplasia than benign cervical epithelium. We sought to determine whether MUC4 expression differs between benign and malignant cervical tissue. Fifty-eight patients with benign, dysplastic, or malignant cervical pathology were identified retrospectively, and representative sections were stained with a mouse monoclonal anti-MUC4 antibody. Semiquantitative analysis was performed on benign, dysplastic, and malignant regions by scoring staining intensity (0: negative, 1: weak, 2: moderate, and 3: strong) and distribution (focal

Original languageEnglish
Pages (from-to)127-133
Number of pages7
JournalInternational Journal of Gynecological Pathology
Issue number2
Publication statusPublished - Mar 2009


All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Obstetrics and Gynecology

Cite this

Munro, E. G., Jain, M., Oliva, E., Kamal, N., Lele, S. M., Lynch, M. P., ... Batra, S. K. (2009). Upregulation of MUC4 in cervical squamous cell carcinoma: Pathologic significance. International Journal of Gynecological Pathology, 28(2), 127-133. https://doi.org/10.1097/PGP.0b013e318184f3e0